Revelation Biosciences, Inc. (REVBW) balance sheet

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

Revelation Biosciences, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31
Cash & Equivalents	11	14	11	13	5.17	3.70	6.50	6.54	12	15	12	14	16	18	5.25	6.20	3.48	7.19	1.27	4.14	6.37	10	4.49	3.32	–	–	–
Short-Term Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.02	0.30	0.39	0.53	–	–	–	–
Cash & Short-Term Investments	11	14	11	13	5.17	3.70	6.50	6.54	12	15	12	14	16	18	5.25	6.20	3.48	7.19	1.27	4.16	6.67	10	5.02	3.32	–	–	–
Prepaid Expenses & Other	0.20	0.09	0.11	0.12	0.19	0.22	0.07	0.12	0.13	0.07	0.08	0.15	0.25	0.33	0.07	0.31	0.58	0.68	0.64	0.02	0.07	0.12	0.11	–	–	–	–
Total Current Assets	12	14	11	13	5.36	3.93	6.57	6.66	12	15	12	14	16	18	5.41	6.51	4.05	7.87	1.91	0.04	0.37	0.52	0.65	3.50	–	–	0.02
Property, Plant & Equipment	0.17	0.14	0.02	0.02	0.04	0.04	0.06	0.08	0.07	0.08	0.07	0.07	0.08	0.08	0.09	0.10	0.10	0.11	0.12	–	–	–	–	–	–	–	–
Gross Property, Plant & Equipment	0.29	0.25	0.12	–	–	–	0.15	0.17	0.15	0.15	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	–	–	–	–	–	–	–	–
Accumulated Depreciation	-0.11	-0.11	-0.10	–	–	–	-0.09	-0.09	-0.08	-0.07	-0.07	-0.06	-0.05	-0.05	-0.04	-0.04	-0.03	-0.02	-0.02	–	–	–	–	–	–	–	–
Machinery & Equipment	0.25	0.25	0.12	–	–	–	0.15	0.17	0.15	0.15	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	0.61	0.67	0.72	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	0.01	–	–	–	–	–	–	–	–
Other Long-Term Assets	0.03	0.03	0.03	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Assets	12	15	12	13	5.40	3.97	6.62	6.74	12	15	12	14	16	18	5.50	6.60	4.15	7.98	2.04	74	74	74	74	3.50	–	–	0.02
Accounts Payable	0.93	0.83	0.58	1.03	0.83	0.63	0.78	3.13	1.28	1.68	1.36	1.26	0.91	0.71	0.55	0.47	0.92	1.46	0.60	0.31	0.23	0.38	0.03	–	–	–	–
Accrued Expenses	0.76	0.47	1.40	0.82	0.74	0.46	1.13	0.93	8.45	0.62	1.15	1.02	0.50	0.97	0.99	1.60	2.17	3.71	1.53	–	–	–	0.03	0.06	–	–	0.02
Current Portion of Leases	0.19	0.12	0.02	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	0.02	–	–	–	–	–	–	–	–
Total Current Liabilities	1.88	1.42	2.00	1.85	1.57	1.09	1.91	4.07	11	5.23	5.56	5.40	4.62	8.10	4.45	4.37	6.00	8.08	2.14	3.74	3.31	2.12	3.43	0.34	–	–	0.03
Long-Term Leases	0.55	0.64	0.72	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.74	0.76	0.75	–	–	–	0	–	–	–	–	–	–	–	–	–	–	–	0.02	–	–	–	–	–	–	–	–
Total Liabilities	2.43	2.06	2.72	1.85	1.57	1.09	1.91	4.07	11	5.23	5.56	5.40	4.62	8.10	4.45	4.37	6.00	8.08	2.14	6.65	6.22	5.03	6.34	3.49	–	–	0.03
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.02	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	–	–	–
Additional Paid-In Capital	66	65	58	58	49	45	45	41	38	38	32	32	32	29	26	26	21	21	14	–	–	–	5.14	0.02	–	–	–
Retained Earnings	-56	-52	-49	-47	-45	-43	-41	-39	-37	-28	-25	-23	-21	-19	-25	-24	-23	-21	-15	-6.60	-5.85	-4.52	-5.69	-0.01	–	–	0.00
Shareholders' Equity	10	13	8.86	11	3.83	2.88	4.71	2.67	1.14	9.47	6.65	8.82	11	10	1.05	2.23	-1.84	-0.10	-0.10	3.66	6.57	8.91	3.41	0.01	0.01	0.01	0.00
Total Equity	10	13	8.86	11	3.83	2.88	4.71	2.67	1.14	9.47	6.65	8.82	11	10	1.05	2.23	-1.84	-0.10	-0.10	3.66	6.57	8.91	3.41	0.01	0.01	0.02	0.00
Total Liabilities & Equity	12	15	12	13	5.40	3.97	6.62	6.74	12	15	12	14	16	18	5.50	6.60	4.15	7.98	2.04	74	74	74	74	3.50	–	–	0.02
Shares Outstanding(shares)	3.91	3.91	1.58	3.59	1.53	0.96	0.04	4.29	1.64	1.63	0.02	0.84	0.84	0.63	0.08	0.09	0.06	0.06	0.04	0.01	0.01	0.01	0.01	0.01	–	–	0.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -131.4%

Financial strength

Current ratio: 6.21
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 610.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.59
Dividend yield: –